Synapse Medicine

Impact 120
Nouvelle-Aquitaine
2017
Founders
Clément Goehrs and Louis Letinier
Description
A medical decision-support platform that uses artificial intelligence to analyze prescriptions and drug interactions.
Legal status
SAS (simplified joint-stock company)
Number of employees
50–200
Website

Receive our newsletter

Thank you, and see you soon in your mailbox!
Oops! A problem has occurred. Please try again.